News by subject: Share Issue

ImmunoGen, Inc., , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the compensation committee of the Company's Board of Directors (the "Compensation Committee") approved, effective...

NOTIFICATION OF TOTAL VOTING RIGHTS AND CAPITAL IN THE COMPANY In accordance with DTR 5.6.1, the Company hereby notifies the following: The Company's issued share capital as at January 31, 2024 consisted of 232,171,182 ordinary shares of 10 pence...

State Street Corporation ("State Street") announced today that it has issued $1.5 billion of depositary shares, each representing a 1/100th ownership interest in a share of its 6.700% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series...

PulteGroup, Inc. announced today that its Board of Directors has approved a $1.5 billion increase to the Company's share repurchase authorization. This increase brings the Company's total share repurchase authorization to $1.8 billion. "Given the...

Sidus Space, Inc. ("Sidus" or the "Company"), a multi-faceted Space and Data-as-a-Service company, today announced the pricing of an underwritten public offering of 1,251,700 shares of its Class A common stock (or pre-funded warrants ("Pre-funded...

Golub Capital BDC, Inc. (the "Company," "we," "us" or "our"), a business development company , announced that it has priced an underwritten public offering of $600 million in aggregate principal amount of 6.000% notes due 2029. The notes will mature...

RiskOn International, Inc. ("RiskOn," or the "Company"), today announced that Randy May, Chairman and Chief Executive Officer, and Jay Puchir, Chief Financial Officer, submitted their resignations, which shall take effect at the close of business on...

CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced the pricing of its upsized...

Caesars Entertainment, Inc. (the "Company") today announced that its indirect wholly-owned subsidiaries, Caesars Resort Collection, LLC ("CRC") and CRC Finco, Inc. ("CRC Finco" and, together with the CRC, the "Issuers"), commenced a cash tender...

Caesars Entertainment, Inc. (the "Company") today announced the pricing of its previously announced offering of $1.5 billion aggregate principal amount of Senior Secured Notes due 2032 (the "Notes") at an interest rate of 6.500% per annum and an...

Q4 Inc. ("Q4" or the "Company"), the leading capital markets access platform, today announced that at its special meeting (the "Special Meeting") of shareholders of the Company ("Shareholders") held today, Shareholders voted to approve the proposed...

Caesars Entertainment, Inc. (the "Company") today announced that the Company, intends to offer, subject to market and other conditions, $1,500.0 million aggregate principal amount of senior secured notes due 2032 (the "Notes") in a private placement...

Adicet Bio, Inc. ("Adicet") , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that it has commenced an underwritten public offering of its...

Vertical Aerospace (Vertical) [NYSE: EVTL], a global aerospace and technology company that is pioneering zero-emissions aviation, announces today that it has secured $50 million in committed funding from founder, majority owner and CEO, Stephen...

Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 895,930 shares of Geron common stock as inducements to newly hired employees in connection...

JPMorgan Chase & Co. ("JPMorgan Chase" or the "Firm") and JPMorgan Chase Financial Company LLC ("JPMorgan Financial") announced today that they have filed a registration statement on Form S-4 (the "Registration Statement") to register JPMorgan...

Caesars Entertainment, Inc. (the "Company") today announced that it has commenced a cash tender offer (the "Tender Offer") for any and all of its outstanding 6.250% Senior Secured Notes due 2025 (the "Notes") on the terms and subject to the...

Viridian Therapeutics, Inc. , a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that it has commenced an underwritten public offering of shares of its common...

Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on January 10, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

Helix Energy Solutions Group, Inc. announced today that it has delivered a notice to the trustee for its 6.75% Convertible Senior Notes due 2026 (the "Notes") under which it has called all of the outstanding Notes for redemption on March 20, 2024...

STEER Technologies Inc. ("STEER" or the "Company") , , an integrated ESG technology platform, is pleased to announce that it has entered into a binding offer letter with a group of arm's length Investors (as defined herein), providing for the...

Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 89,770 shares of Evolus and an aggregate of 82,730...

NETSTREIT Corp. (the "Company") announced today that it has closed its previously announced public offering of 11,040,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase additional shares, at a...

Mirum Pharmaceuticals, Inc. today announced that on January 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 50,950 shares of common stock and 25,480...

NETSTREIT Corp. (the "Company") announced today that it has priced a public offering of 9,600,000 shares of its common stock at a public offering price of $18.00 per share in connection with the forward sale agreements described below. The Company...

NETSTREIT Corp. (the "Company") announced today that it has commenced a public offering of 8,000,000 shares of its common stock in connection with the forward sale agreements described below, which is subject to market and other conditions. In...

Acadia Realty Trust ("Acadia" or the "Company") announced today the pricing of an underwritten offering of 6,900,000 common shares (inclusive of the underwriters' option to purchase 900,000 additional shares) at a price to the public of $16.75 per...

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced that the Compensation Committee of Gossamer's...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that it has...

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that...

Core & Main Inc. , a leader in advancing reliable infrastructure with local service, nationwide, today announced the launch of an underwritten secondary public offering of 15 million shares of its Class A common stock by certain selling stockholders....

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on January 2, 2024, the...

NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 19,251 shares of its common stock to six new employees. The awards were granted...

EnerSys ("EnerSys" or the "Company") announced today the pricing of $300 million aggregate principal amount of its 6.625% senior notes due 2032 (the "Notes") at an issue price of 100%. The Notes will be unsecured, unsubordinated obligations of the...

CCC Intelligent Solutions Holdings Inc. (the "Company") today announced the proposed secondary offering of 20 million shares of the Company's common stock (the "Offering") by affiliates of Advent International, L.P. (the "Selling Stockholders"). The...

EnerSys ("EnerSys" or the "Company") announced today that it intends to offer, subject to market and customary conditions, $300 million aggregate principal amount of senior notes due 2032 (the "Notes"). The Notes will be unsecured, unsubordinated...

Arrowhead Pharmaceuticals, Inc. today announced the pricing of an underwritten registered offering of 15,790,000 shares of its common stock, par value $0.001 per share ("Common Stock"), offered at a price of $28.50 per share, before underwriting...

Williams announced today that it has priced a public offering of $1.1 billion of its 4.900% Senior Notes due 2029 at a price of 99.839 percent of par and $1.0 billion of its 5.150% Senior Notes due 2034 at a price of 99.975 percent of par. The...

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has commenced an underwritten public offering, subject to market and...

NOTIFICATION OF TOTAL VOTING RIGHTS AND CAPITAL IN THE COMPANY In accordance with DTR 5.6.1, the Company hereby notifies the following: The Company's issued share capital as at December 31, 2023 consisted of 232,171,182 ordinary shares of 10...

Modiv Industrial, Inc. ("Modiv Industrial," "Modiv" or the "Company") , the only public REIT exclusively focused on acquiring industrial manufacturing real estate properties, today announced the declaration of a stock distribution of Generation...

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced it has...

Netcapital Inc. (the "Company") , a digital private capital markets ecosystem, today announced the closing of its previously announced public offering of 16,000,000 shares of common stock (or pre-funded warrants in lieu thereof), together with series...

Adani Green Energy Ltd ("AGEL"), India's largest and the world's leading renewable energy developer, announced that the Board of Directors of AGEL have approved a preferential issuance of warrants to the Promoters of AGEL for a quantum of INR 9,350...

Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 417,490 shares of Geron common stock as inducements to newly hired employees in connection...

Stratasys Ltd. ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that its Board of Directors has unanimously adopted a limited duration shareholder rights plan (the "Rights Plan"). The Rights Plan, which...

Gold Reserve Inc. ("the Company") announces the grant of 145,000 stock options to David Knight, a director of the Company. These stock options, which were granted on December 14, 2023, are exercisable at US $2.52, have a 10-year term and have been...

Acadia Pharmaceuticals Inc. today announced that on December 13, 2023, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 33,647 shares of...

bluebird bio, Inc. ("bluebird") today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. bluebird also intends to grant the underwriters a 30-day option to purchase up to an additional...